Ceribell (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 26, 2018
- Vertical
- Healthcare Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Company Description
- Ceribell is focused on making EEG widely available, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The Ceribell EEG System received FDA 510(k) clearance in 2017 and is commercially available in the United States.
- Market
- Medical Devices
- Location
- Mountain View, California, United States
- Coinvestors
- LivaNova, Optimas Capital Partners Fund, The Rise Fund, UC